{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-029663","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.986503+00:00","generated_at":"2026-06-17T01:59:55.716963+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avra Medical Robotics enters $3M investment agreement with Dr. Moll convertible into 7% of post-merger equity","bullets":["Dr. Moll provides additional $1M (total $3M) interim financing for CardioVentures working capital.","Upon merger close, Moll receives 7% of SSII on fully-diluted basis; Srivastava forfeits 2% of CardioVentures shares.","If merger not consummated by April 14, 2023, Moll has put right to cash repayment at 7% annual return (12% if late).","Merger would rename company to SS Innovations International, Inc. (SSII) and combine with CardioVentures.","Financing priced at $100M pre-money valuation; anti-dilution adjustment if future capital raised below that."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-029663","json":"https://secwatch.observer/filing/0001213900-23-029663.json","markdown":"https://secwatch.observer/filing/0001213900-23-029663.md","text":"https://secwatch.observer/filing/0001213900-23-029663.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390023029663/0001213900-23-029663-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390023029663/ea176767-8k_avramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:59:55.716963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a1b0001fe68518037dbfd9e5b6856fc6b4c37f7","claim":"SS Innovations International, Inc. entered into Investment Agreement with Dr. Frederic Moll valued at $1,000,000 in financing (effective 2023-04-07).","evidence_excerpt":"On April 7, 2023, we entered into an Investment Agreement (the “ Investment Agreement ”) with Dr. Frederic Moll (“ Dr. Moll ”), pursuant to which, on April 10, 2023, Dr. Moll, in addition to $2,000,000 in financing previously provided to the Company (the “ Initial Investment ”), provided us with an additional $1,000,000 in financing (the “ Additional Investment ,” and together with the Initial Investment, the “ Interim Financing ”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390023029663/0001213900-23-029663-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Dr. Frederic Moll"},{"label":"Value","value":"$1,000,000 in financing"},{"label":"Effective","value":"2023-04-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}